Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

@inproceedings{Lugaresi2012PatientAT,
  title={Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study},
  author={Alessandra Lugaresi and Ciro De Florio and Vincenzo Brescia-Morra and Salvatore Cottone and Paolo Bellantonio and Marinella Clerico and Diego Centonze and Antonio Uccelli and Maria di Ioia and G De Luca and Andrea Marcellusi and Andrea Paolillo},
  booktitle={BMC neurology},
  year={2012}
}
BACKGROUND Achieving good adherence to self-injected treatments for multiple sclerosis can be difficult. Injection devices may help to overcome some of the injection-related barriers to adherence that can be experienced by patients. We sought to assess short-term adherence to, and tolerability of, interferon (IFN) β-1a administered via electronic autoinjection device in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS BRIDGE (RebiSmart to self-inject Rebif serum-free… CONTINUE READING
BETA
Highly Cited
This paper has 44 citations. REVIEW CITATIONS
Tweets
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 26 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Optimizing adherence to multiple sclerosis therapies

  • B Singer, S Lucas, K Kresa-Reahl, A Perrin Ross, P Blake
  • Int J MS Care ,
  • 2008
Highly Influential
4 Excerpts

Final results from a 12-week, phase IIIb trial to evaluate an electronic autoinjector in patients with relapsing multiple sclerosis

  • B Singer, S Wray, +6 authors F Dangond
  • Neurology
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…